Naloxone

Purdue Pharma announced it plans to provide up to $9 million in additional financial support for a low-cost over-the-counter intranasal naloxone spray.

Women receiving buprenorphine-naloxone therapy for the treatment of opioid use disorder during pregnancy had similar outcomes vs. buprenorphine therapy alone in terms of maternal and neonatal health, data show.

The FDA announced findings from a preliminary assessment that indicate certain naloxone products may be safely used without a prescription to prevent opioid overdose deaths.

HarborPath, a North Carolina-based nonprofit organization providing life-saving medications in 17 states, announced a partnership with FFF Enterprises to distribute naloxone to combat the opioid crisis.

Biden administration officials recently discussed several initiatives within a multi-pronged, multi-agency collaboration that they said are needed to address the overdose epidemic.

Researchers have created a wearable device that can detect and reverse opioid overdoses, according to study results.

Researchers observed a substantial reduction in filled naloxone prescriptions that exceeded a reduction in filled opioid prescriptions and filled prescriptions for any medication during the COVID-19 pandemic.

A hospital intervention designed to raise awareness of naloxone and remove prescribing barriers was associated with a 584% increase in prescriptions among patients at high risk for an opioid overdose, according to recent research.

The FDA today announced approval of a higher dose naloxone hydrochloride nasal spray product for opioid overdose treatment.

The American Heart Association published a scientific statement describing the pathophysiology and treatment options for people with opioid-associated out-of-hospital cardiac arrest.